Advertisement
Screener

Myovant Sciences Ltd. Increase Decrease In Operating Lease Liability

Myovant Sciences Ltd. Increase Decrease In Operating Lease Liability

Myovant Sciences Ltd. reported Increase Decrease In Operating Lease Liability of -$1.62 million for the 9-month period ending 2022-12-31, per its 10-Q filed 2023-01-26.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2023-01-26

  • Myovant Sciences Ltd. increase decrease in operating lease liability for the quarter ending 2022-12-31 was -$591.00K.
  • Myovant Sciences Ltd. increase decrease in operating lease liability for the quarter ending 2022-09-30 was -$525.00K.
  • Myovant Sciences Ltd. increase decrease in operating lease liability for the quarter ending 2022-06-30 was -$502.00K.
  • Myovant Sciences Ltd. increase decrease in operating lease liability for the quarter ending 2022-03-31 was -$481.00K.
  • Myovant Sciences Ltd. increase decrease in operating lease liability for fiscal 2022 was -$1.81M.
  • Myovant Sciences Ltd. increase decrease in operating lease liability for fiscal 2021 was -$1.52M.
  • Myovant Sciences Ltd. increase decrease in operating lease liability for fiscal 2020 was -$882.00K.
Period endIncrease Decrease In Operating Lease Liability 3 monthIncrease Decrease In Operating Lease Liability 6 monthIncrease Decrease In Operating Lease Liability 9 monthIncrease Decrease In Operating Lease Liability 12 month
2022-12-31-$591.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-26
-$1.12M
derived: sum of 2 quarters · filed 2023-01-26
-$1.62M
10-Q · filed 2023-01-26
-$2.10M
derived: sum of 4 quarters · filed 2023-01-26
2022-09-30-$525.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-26
-$1.03M
10-Q · filed 2022-10-26
-$1.51M
derived: sum of 3 quarters · filed 2022-10-26
-$1.97M
derived: sum of 4 quarters · filed 2023-01-26
2022-06-30-$502.00K
10-Q · filed 2022-07-27
-$983.00K
derived: sum of 2 quarters · filed 2022-07-27
-$1.44M
derived: sum of 3 quarters · filed 2023-01-26
-$1.88M
derived: sum of 4 quarters · filed 2023-01-26
2022-03-31-$481.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11
-$938.00K
derived: sum of 2 quarters · filed 2023-01-26
-$1.38M
derived: sum of 3 quarters · filed 2023-01-26
-$1.81M
10-K · filed 2022-05-11
2021-12-31-$457.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-26
-$901.00K
derived: sum of 2 quarters · filed 2023-01-26
-$1.33M
10-Q · filed 2023-01-26
-$1.73M
derived: sum of 4 quarters · filed 2023-01-26
2021-09-30-$444.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-26
-$869.00K
10-Q · filed 2022-10-26
-$1.27M
derived: sum of 3 quarters · filed 2022-10-26
-$1.66M
derived: sum of 4 quarters · filed 2022-10-26
2021-06-30-$425.00K
10-Q · filed 2022-07-27
-$829.00K
derived: sum of 2 quarters · filed 2022-07-27
-$1.21M
derived: sum of 3 quarters · filed 2022-07-27
-$1.58M
derived: sum of 4 quarters · filed 2022-07-27
2021-03-31-$404.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11
-$788.00K
derived: sum of 2 quarters · filed 2022-05-11
-$1.16M
derived: sum of 3 quarters · filed 2022-05-11
-$1.52M
10-K · filed 2022-05-11
2020-12-31-$384.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-01-26
-$756.00K
derived: sum of 2 quarters · filed 2022-01-26
-$1.11M
10-Q · filed 2022-01-26
2020-09-30-$372.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-10-26
-$728.00K
10-Q · filed 2021-10-26
2020-06-30-$356.00K
10-Q · filed 2021-07-28
2020-03-31-$882.00K
10-K · filed 2022-05-11